Skip to main content

Table 2 Outcomes of CBP and non-CBP groups

From: Continuous Blood purification on Influenza-Associated Neurological Disease in children: a retrospective cohort study

Outcomes

CBP group (n=18)

Non-CBP group (n=12)

p

28-day mortality, n (%)a

2 (11.11)

6 (50)

0.034*

Glasgow score (median [IQR])b

7.00 (4.00-7.25)

3.50 (3.00-5.75)

0.021*

PIM-2 score (median [IQR])b

11.00 (7.78-22.55)

43.80 (9.28-85.03)

0.040*

Critical illness score (median [IQR])b

93 (88.00-94.00)

81 (77.00-93.50)

0.038*

PICU stay (median [IQR]) (d)c

19.00 (15.00-22.50)

10.00 (4.00-12.00)

0.008*

Ventilation time (median [IQR]) (d)c

7.50 (5.75-15.25)

5.50 (4.00-6.75)

0.060

hospitalization costs(median [IQR]) (US dollars)c

11350.67 (8670.36-16802.95)

6195.63 (3246.95-8000.03)

0.008*

  1. CBP Continuous blood purification, IQR Interquartile range, PIM-2 Pediatric index of mortality 2, PICU Pediatric intensive care unit
  2. * p<0.05
  3. a p<0.05 The 28-day mortality using the Chi-squared test
  4. b p<0.05 The Glasgow score, PIM-2 score, Critical ill score using Mann-Whitney U test
  5. c p<0.05 The PICU stay, Ventilation time, Hospitalization costs using nonparametric tests/compare medians across groups